62.82 USD
+0.74 (+1.19%)
62.82 USD
0 (0%)
We assign a fundamental rating of 5 out of 10 to LIVN. LIVN was compared to 184 industry peers in the Health Care Equipment & Supplies industry. LIVN has only an average score on both its financial health and profitability. LIVN may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
In the past year LIVN was profitable.
LIVN had a positive operating cash flow in the past year.
In multiple years LIVN reported negative net income over the last 5 years.
LIVN had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of -8.50%, LIVN is doing good in the industry, outperforming 63.64% of the companies in the same industry.
LIVN has a better Return On Equity (-18.79%) than 60.96% of its industry peers.
LIVN's Return On Invested Capital of 8.35% is amongst the best of the industry. LIVN outperforms 86.10% of its industry peers.
The Average Return On Invested Capital over the past 3 years for LIVN is significantly below the industry average of 8.82%.
The last Return On Invested Capital (8.35%) for LIVN is above the 3 year average (3.45%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.5% | ||
| ROE | -18.79% | ||
| ROIC | 8.35% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 14.95%, LIVN belongs to the top of the industry, outperforming 82.89% of the companies in the same industry.
LIVN's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 68.50%, LIVN is doing good in the industry, outperforming 73.80% of the companies in the same industry.
In the last couple of years the Gross Margin of LIVN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.95% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% |
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
2. Health
2.1 Basic Checks
LIVN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LIVN has been increased compared to 1 year ago.
The number of shares outstanding for LIVN has been increased compared to 5 years ago.
LIVN has a worse debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 1.74, we must say that LIVN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.74, LIVN is in line with its industry, outperforming 56.15% of the companies in the same industry.
LIVN has a debt to FCF ratio of 2.27. This is a good value and a sign of high solvency as LIVN would need 2.27 years to pay back of all of its debts.
LIVN's Debt to FCF ratio of 2.27 is amongst the best of the industry. LIVN outperforms 86.63% of its industry peers.
LIVN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of LIVN (0.30) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.27 | ||
| Altman-Z | 1.74 |
ROIC/WACC0.97
WACC8.62%
2.3 Liquidity
LIVN has a Current Ratio of 1.33. This is a normal value and indicates that LIVN is financially healthy and should not expect problems in meeting its short term obligations.
LIVN's Current ratio of 1.33 is on the low side compared to the rest of the industry. LIVN is outperformed by 79.68% of its industry peers.
A Quick Ratio of 1.12 indicates that LIVN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.12, LIVN is doing worse than 73.80% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
LIVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.24%, which is quite good.
Measured over the past 5 years, LIVN shows a small growth in Earnings Per Share. The EPS has been growing by 1.82% on average per year.
Looking at the last year, LIVN shows a quite strong growth in Revenue. The Revenue has grown by 8.63% in the last year.
LIVN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.94% yearly.
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
3.2 Future
The Earnings Per Share is expected to grow by 13.80% on average over the next years. This is quite good.
The Revenue is expected to grow by 7.88% on average over the next years.
EPS Next Y16.74%
EPS Next 2Y11.9%
EPS Next 3Y10.54%
EPS Next 5Y13.8%
Revenue Next Year10.7%
Revenue Next 2Y8.71%
Revenue Next 3Y7.93%
Revenue Next 5Y7.88%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 16.32, which indicates a correct valuation of LIVN.
85.03% of the companies in the same industry are more expensive than LIVN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LIVN to the average of the S&P500 Index (26.39), we can say LIVN is valued slightly cheaper.
LIVN is valuated correctly with a Price/Forward Earnings ratio of 14.89.
LIVN's Price/Forward Earnings ratio is rather cheap when compared to the industry. LIVN is cheaper than 87.17% of the companies in the same industry.
LIVN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.32 | ||
| Fwd PE | 14.89 |
4.2 Price Multiples
84.49% of the companies in the same industry are more expensive than LIVN, based on the Enterprise Value to EBITDA ratio.
LIVN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. LIVN is cheaper than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.92 | ||
| EV/EBITDA | 13.06 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
LIVN has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.97
PEG (5Y)8.99
EPS Next 2Y11.9%
EPS Next 3Y10.54%
5. Dividend
5.1 Amount
LIVN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
62.82
+0.74 (+1.19%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners105.47%
Inst Owner Change2.38%
Ins Owners0.28%
Ins Owner Change0.34%
Market Cap3.43B
Revenue(TTM)1.35B
Net Income(TTM)-217.49M
Analysts82.5
Price Target69.09 (9.98%)
Short Float %4.21%
Short Ratio4.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.36%
Min EPS beat(2)18.42%
Max EPS beat(2)20.31%
EPS beat(4)3
Avg EPS beat(4)12.75%
Min EPS beat(4)-0.89%
Max EPS beat(4)20.31%
EPS beat(8)7
Avg EPS beat(8)18.55%
EPS beat(12)11
Avg EPS beat(12)18.19%
EPS beat(16)14
Avg EPS beat(16)14.3%
Revenue beat(2)2
Avg Revenue beat(2)3.07%
Min Revenue beat(2)2.12%
Max Revenue beat(2)4.01%
Revenue beat(4)3
Avg Revenue beat(4)1.56%
Min Revenue beat(4)-2.64%
Max Revenue beat(4)4.01%
Revenue beat(8)7
Avg Revenue beat(8)2.79%
Revenue beat(12)11
Avg Revenue beat(12)3.51%
Revenue beat(16)13
Avg Revenue beat(16)2.69%
PT rev (1m)6.44%
PT rev (3m)6.44%
EPS NQ rev (1m)-0.14%
EPS NQ rev (3m)-9.87%
EPS NY rev (1m)2.86%
EPS NY rev (3m)2.92%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-0.88%
Revenue NY rev (1m)1.96%
Revenue NY rev (3m)1.96%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.32 | ||
| Fwd PE | 14.89 | ||
| P/S | 2.54 | ||
| P/FCF | 17.92 | ||
| P/OCF | 13.69 | ||
| P/B | 2.96 | ||
| P/tB | 26.06 | ||
| EV/EBITDA | 13.06 |
EPS(TTM)3.85
EY6.13%
EPS(NY)4.22
Fwd EY6.72%
FCF(TTM)3.51
FCFY5.58%
OCF(TTM)4.59
OCFY7.31%
SpS24.7
BVpS21.19
TBVpS2.41
PEG (NY)0.97
PEG (5Y)8.99
Graham Number42.84
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -8.5% | ||
| ROE | -18.79% | ||
| ROCE | 11.65% | ||
| ROIC | 8.35% | ||
| ROICexc | 13.32% | ||
| ROICexgc | 247.47% | ||
| OM | 14.95% | ||
| PM (TTM) | N/A | ||
| GM | 68.5% | ||
| FCFM | 14.19% |
ROA(3y)-0.17%
ROA(5y)-4.24%
ROE(3y)-0.33%
ROE(5y)-8.58%
ROIC(3y)3.45%
ROIC(5y)N/A
ROICexc(3y)4.13%
ROICexc(5y)N/A
ROICexgc(3y)10.29%
ROICexgc(5y)N/A
ROCE(3y)4.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y4.42%
ROICexc growth 3Y38.42%
ROICexc growth 5Y24.6%
OM growth 3Y41.76%
OM growth 5Y18.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.63%
GM growth 5Y0.8%
F-Score6
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 2.27 | ||
| Debt/EBITDA | 1.42 | ||
| Cap/Depr | 132% | ||
| Cap/Sales | 4.39% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 101.69% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.33 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.74 |
F-Score6
WACC8.62%
ROIC/WACC0.97
Cap/Depr(3y)78.91%
Cap/Depr(5y)67.73%
Cap/Sales(3y)3.13%
Cap/Sales(5y)3.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y16.71%
EPS 5Y1.82%
EPS Q2Q%23.33%
EPS Next Y16.74%
EPS Next 2Y11.9%
EPS Next 3Y10.54%
EPS Next 5Y13.8%
Revenue 1Y (TTM)8.63%
Revenue growth 3Y6.58%
Revenue growth 5Y2.94%
Sales Q2Q%12.48%
Revenue Next Year10.7%
Revenue Next 2Y8.71%
Revenue Next 3Y7.93%
Revenue Next 5Y7.88%
EBIT growth 1Y51.21%
EBIT growth 3Y51.09%
EBIT growth 5Y22.46%
EBIT Next Year37.27%
EBIT Next 3Y17.16%
EBIT Next 5Y3.36%
FCF growth 1Y2161.93%
FCF growth 3Y20.82%
FCF growth 5YN/A
OCF growth 1Y532.01%
OCF growth 3Y21.3%
OCF growth 5YN/A
LIVANOVA PLC / LIVN FAQ
Can you provide the ChartMill fundamental rating for LIVANOVA PLC?
ChartMill assigns a fundamental rating of 5 / 10 to LIVN.
What is the valuation status for LIVN stock?
ChartMill assigns a valuation rating of 7 / 10 to LIVANOVA PLC (LIVN). This can be considered as Undervalued.
How profitable is LIVANOVA PLC (LIVN) stock?
LIVANOVA PLC (LIVN) has a profitability rating of 6 / 10.
What is the valuation of LIVANOVA PLC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for LIVANOVA PLC (LIVN) is 16.32 and the Price/Book (PB) ratio is 2.96.
How financially healthy is LIVANOVA PLC?
The financial health rating of LIVANOVA PLC (LIVN) is 4 / 10.